Cell Line : NCI-H835
Cellosaurus Index : CVCL_1593
Cellosaurus ID : NCI-H835
CCLE Name
: NCIH835_LUNG
GDSC1 Name
, GDSC2 Name
: NCI-H835
Cancer Type : lung
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| NCI-H835 | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | 5-azacytidine | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H835 | 5-Fluorouracil | GDSC2 | 0.0200 | 32.0000 |
|
| NCI-H835 | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | A-366 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | ABT737 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | Afatinib | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| NCI-H835 | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | AGK-2 | GDSC2 | 0.0040 | 4.0000 |
|
| NCI-H835 | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| NCI-H835 | Alisertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Alpelisib | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H835 | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | ascorbate (vitamin C) | GDSC2 | 2.0011 | 2000.0000 |
|
| NCI-H835 | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | AT13148 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | AT7867 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Axitinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H835 | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | AZD1208 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | AZD1332 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H835 | AZD2014 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H835 | AZD4547 | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| NCI-H835 | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| NCI-H835 | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | AZD5438 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | AZD5582 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H835 | AZD6482 | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H835 | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | AZD7762 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H835 | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | AZD8055 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H835 | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| NCI-H835 | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | BAY-MPS-combo 2 (paclitaxel 1 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| NCI-H835 | BAY-MPS-combo-1 (paclitaxel 5 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| NCI-H835 | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| NCI-H835 | BDP-00009066 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | BI-2536 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H835 | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | BIBR-1532 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Bicalutamide | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | Bleomycin (50 uM) | GDSC1,GDSC2 | 0.0400 | 50.0000 |
|
| NCI-H835 | BMS-536924 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | BMS-754807 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Bortezomib | GDSC2 | 0.0000 | 0.0200 |
|
| NCI-H835 | Bosutinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H835 | BPD-00008900 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | BX795 | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H835 | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H835 | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| NCI-H835 | CCT-018159 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | CCT007093 | GDSC1 | 0.0258 | 6.6000 |
|
| NCI-H835 | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| NCI-H835 | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| NCI-H835 | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| NCI-H835 | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| NCI-H835 | CHIR-99021 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | Cisplatin | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| NCI-H835 | CPI-637 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Crizotinib | GDSC2 | 0.0080 | 10.0000 |
|
| NCI-H835 | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | CT7033-2 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Cytarabine | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H835 | Dabrafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| NCI-H835 | Dactolisib | GDSC1,GDSC2 | 0.0003 | 0.2500 |
|
| NCI-H835 | Daporinad | GDSC1,GDSC2 | 0.0001 | 1.0000 |
|
| NCI-H835 | Dasatinib | GDSC2 | 0.0010 | 2.0000 |
|
| NCI-H835 | Docetaxel | GDSC1,GDSC2 | 0.0000 | 0.0125 |
|
| NCI-H835 | Doramapimod | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Doxorubicin | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H835 | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Elesclomol | GDSC1 | 0.0008 | 0.2000 |
|
| NCI-H835 | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | Epirubicin | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H835 | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Erlotinib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H835 | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H835 | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | Foretinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H835 | Fulvestrant | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| NCI-H835 | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Gefitinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H835 | Gemcitabine | GDSC1,GDSC2 | 0.0001 | 10.0000 |
|
| NCI-H835 | glutathione | GDSC2 | 0.6403 | 640.0000 |
|
| NCI-H835 | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| NCI-H835 | GSK-LSD1-2HCl | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H835 | GSK1059615 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | GSK1904529A | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | GSK269962A | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H835 | GSK2830371 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | GSK343 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H835 | HKMTI-1-005 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | I-BET151 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | IAP_5620 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | IC-87114 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | ICL-SIRT078 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | IOX2 | GDSC1 | 0.0004 | 0.1000 |
|
| NCI-H835 | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Irinotecan | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | JQ1 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| NCI-H835 | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H835 | KU-55933 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | KU-60019 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | Lapatinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H835 | LGK974 | GDSC2 | 0.0050 | 10.0000 |
|
| NCI-H835 | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | Linsitinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Luminespib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H835 | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | Methotrexate | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| NCI-H835 | MG-132 | GDSC2 | 0.0156 | 4.0000 |
|
| NCI-H835 | MIM1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Mirin | GDSC1 | 0.3906 | 100.0000 |
|
| NCI-H835 | MK-1775 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | MK-2206 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H835 | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H835 | Mycophenolic acid | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | N25720-51-A1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | N27922-53-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | N29087-69-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | N30652-18-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Navitoclax | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| NCI-H835 | Nilotinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H835 | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H835 | Nutlin-3a | GDSC1,GDSC2 | 0.0080 | 10.0000 |
|
| NCI-H835 | NVP-ADW742 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Obatoclax Mesylate | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Olaparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | OSI-027 | GDSC2 | 0.0040 | 4.0000 |
|
| NCI-H835 | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H835 | Oxaliplatin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Paclitaxel | GDSC2 | 0.0000 | 0.0100 |
|
| NCI-H835 | Palbociclib | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| NCI-H835 | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H835 | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H835 | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H835 | PBD-288 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H835 | PD0325901 | GDSC1,GDSC2 | 0.0003 | 2.5000 |
|
| NCI-H835 | PD173074 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| NCI-H835 | Pevonedistat | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| NCI-H835 | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | PF-4708671 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | PFI-1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | PFI3 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | Pictilisib | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| NCI-H835 | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | Piperlongumine | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| NCI-H835 | PLX-4720 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | POMHEX | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | Rapamycin | GDSC2 | 0.0000 | 0.0200 |
|
| NCI-H835 | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H835 | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| NCI-H835 | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H835 | Sapitinib | GDSC2 | 0.0050 | 10.0000 |
|
| NCI-H835 | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H835 | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | SB505124 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H835 | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H835 | Selumetinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Sepantronium bromide | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Serdemetan | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | SGC0946 | GDSC1 | 0.0020 | 0.5000 |
|
| NCI-H835 | SL0101 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | SN-38 | GDSC1,GDSC2 | 0.0000 | 0.1000 |
|
| NCI-H835 | Sorafenib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Sphingosine Kinase 1 Inhibitor II | GDSC1 | 0.0100 | 2.5600 |
|
| NCI-H835 | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| NCI-H835 | SU11274 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H835 | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Tamoxifen | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Tanespimycin | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H835 | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H835 | Taselisib | GDSC2 | 0.0050 | 10.0000 |
|
| NCI-H835 | Telomerase Inhibitor IX | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Temozolomide | GDSC1,GDSC2 | 0.0300 | 30.0000 |
|
| NCI-H835 | Temsirolimus | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| NCI-H835 | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | THR-101 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | THR-102 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | THR-103 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | Trametinib | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H835 | Tretinoin | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | TW 37 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H835 | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | Ulixertinib | GDSC2 | 0.0020 | 10.0000 |
|
| NCI-H835 | UMI-77 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | UNC0379 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | UNC0638 | GDSC1,GDSC2 | 0.0050 | 20.0000 |
|
| NCI-H835 | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| NCI-H835 | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| NCI-H835 | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Veliparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H835 | Vinblastine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H835 | Vinorelbine | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H835 | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Vorinostat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H835 | VTP-A | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H835 | VTP-B | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H835 | VX-11e | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| NCI-H835 | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H835 | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H835 | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| NCI-H835 | XAV939 | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H835 | YK-4-279 | GDSC1,GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H835 | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H835 | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC